Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

Abstract
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is th